TECX: McNamara Peter discloses securities transactions
By AlphaYouPublished Form 4
McNamara Peter
Reporting filer
McNamara Peter reported Tax/exercise withholding in Tectonic Therapeutic, Inc.: 444 units of Common Stock, dated 2026-09-25. The full Form 4 contains 2 transaction entries.
- Disclosed
- Oct 2, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | McNamara Peter | 2026-09-25 | F | Tax/exercise withholding | 444 | 23.67 | 54,841 | 7 days | Filed terms
|
| Common Stock | McNamara Peter | 2026-09-30 | S | Sale | 536 | 23.04 | 54,305 | 2 days | Filed terms
|
Common Stock
- Owner
- McNamara Peter
- Date
- 2026-09-25
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 444
- Price
- 23.67
- Following holdings
- 54,841
- Reporting delay
- 7 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-25
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- transaction Shares: 444
- id: F1
- transaction Price Per Share: 23.67
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 54841
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- McNamara Peter
- Date
- 2026-09-30
- Code
- S
- Action
- Sale
- Quantity
- 536
- Price
- 23.04
- Following holdings
- 54,305
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F2
- transaction Shares: 536
- transaction Price Per Share: 23.04
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 54305
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- McNamara Peter: Chief Scientific Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units granted on September 25, 2025.
- F2: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2025.
- F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.61 to $23.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Original sources
Prepared automatically from public filing data. Report a correction.